Sotac Pharmaceuticals Limited — Board Meeting, 12-11-2025: Outcome of Board Meeting
12-11-2025 | 06:25 pm
12-11-2025 | 06:25 pm
Sotac Pharmaceuticals' board approved the consolidated financial results for the half-year ending September 30, 2025. Revenue from operations stood at ₹37.01 Cr, with a profit of ₹2.45 Cr. EPS for the half-year was ₹2.21.
No comments yet. Be the first to comment!
